ArticleCancers2023

Chromatin Remodelling Molecule ARID1A Determines Metastatic Heterogeneity in Triple-Negative Breast Cancer by Competitively Binding to YAP.

Ye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.